IAJPS 2018, 05 (03), 1885-1897 Sheikh Ahmed et al ISSN 2349-7750

CODEN [USA]: IAJPBB ISSN: 2349-7750

INDO AMERICAN JOURNAL OF

PHARMACEUTICAL SCIENCES
http://doi.org/10.5281/zenodo.1211635

Available online at: http://www.iajps.com Review Article

HEPATITIS C VIRUS INFECTION: PREVENTION AND

CONTROL - A MINI REVIEW
Binish Baig1, Sheikh Ahmed2, Dr Kaleemullah Mandokhail1, Dr Fazal Ur Rehman1
Zulfiqar Ali3, Naeema Anwar2, and Dr Ashif Sajjad2
1
Department of Microbiology, University of Balochistan, Quetta, Pakistan.
2
Institute of Bio-Chemistry, University of Balochistan, Quetta Pakistan.
3
Directorate of Agriculture Research Usta Muhammad, Pakistan.
Abstract:
It is estimated that around more than 2% of the population of world is suffering with hepatitis C virus and death
cases because of cirrhosis and liver cancer is more than 350000.The load and epidemiology of HCV infection is
different in the different parts of the world. It vary with country particular prevalence range from <1%- >10%. In
comparison with USA and other urbanized countries the spread of infection in poor countries commonly outcome of
contact to infected blood in society settings and healthcare centers.
HCV management programs must be country specific which may be different by background and rank of economic
progress. Worldwide HCV is a main cause of liver disease and in future it would be a major cause of morbidity and
mortality. The complication related to the geographic allocation of HCV infection and its linked risk factor
increases its progression. No vaccine is available for HCV and no later than exposure for HCV prophylaxis, so the
focal point of most important escaping work must be secure supply of blood, protected management care and people
who use drug decrease the number of those people in developing countries.
Key words: Hepatitis, Genome, Treatment. Epidemiology
Corresponding author:
Sheikh Ahmed, QR code
Institute of Bio-Chemistry,
University of Balochistan,
Quetta, Pakistan

Please cite this article in press Sheikh Ahmed et al., Hepatitis C Virus Infection: Prevention and Control - A Mini
Review, Indo Am. J. P. Sci, 2018; 05(03).

www.iajps.com Page 1885

 IAJPS 2018, 05 (03), 1885-1897
INTRODUCTION:
Hepatitis C virus (HCV) was early defined like the
major viral mediator of non A-non-B inflammation of
liver in 1989. HCV is a part of family Flaviviridae
and has been documented as chief causative
representative of chronic liver infection [1]. Now it is
well established that main etiological cause of non-
B, non-A hepatitis inflammation is HCV (PT-
NANBH), and it is metropolitan circulation (genome-
2).This virus have a +ive strand RNA genome made
out of a 5′-non-coding region (NCR), which
incorporate (IRES) that is an inward ribosome
passage site, an unlock perusing sketch out that
encodes basic non auxiliary proteins and 3′-NCR.
Protein which shape viral molecule fit in the center
protein; furthermore envelop glycoprotein E1 and E2.
Non basic protein enter the p7 unit channel, the NS3
serine protease, NS2-3 protease, the NS4A
polypeptide, and RNA helicase, NS5A proteins and
the NS5B RNA-subordinate RNA polymerase
(RdRp) [2].
The usual account of HCV infection is express by an
association toward cirrhosis in 6-23% at middle of 3
to 4 years after transplantation by a total possibility
of HCV associated cirrhosis assessed to achieve 30%
at five years of growth. The expansion of cirrhosis is
linked to reduce unit and continued existence of the
patient [3]. Hence the infected person and medical
practitioner have need of an extensive knowledge of
the usual history of infection as they deal with the
healing administration and re transplantation for
cirrhosis of liver.
In this manner the focus of this research was to state
the usual history of HCV cirrhosis following LT and
differentiate analytical mechanism in support of
survival, decomposition after the infection. (Firpi et
al., 2009) [4]. The usual background of HCV
infectivity is commonly describe by the alter from
severe to never ending disease which can develop
from an elongated no symptomatic state up to
Hepatomegaly.
Healing from severe illness is assessed to happen in
10-25% of the people [5]. HCV co-infection among
HIV or HBV has been come into view to speed up
the way of persistent HCV and promote movement to
hepatocellular carcinoma and cirrhosis. In this way
person infected with HCV must be test for HIV and
HBV indicator within sight of hazard feature.
Therefore co-infection can regulate recuperative
system and medical administration. There is very
small information regarding the treatment of persons
with HBV/HCV co-infection [6]. The rise of
hepatocellular carcinoma and liver
www.iajps.com
Sheikh Ahmed et al ISSN 2349-7750
cirrhosis later than in HCV infected people are of
definite concern.
Hence the load of HCV for continual well being
human society and services framework is liberal [7].
Information is not sufficient on the other hand liver
transplant recipient who completed the phase of
cirrhosis 5, 8 or fibrosis 4 in their join. In the immune
competent public place , information from a some
vast test advised that the result of paid patients with
HCV cirrhosis is large, in any occurrence among the
5 years to prop up views over transplantation [8].
The information revealed by WHO evaluated that the
predominance of HCV disease is 2.2%, and in excess
of one million new cases were accounted for every
year. Moreover, an expected 27% cirrhosis and 25%
hepato-cell carcinomas (HCC) overall happen within
HCV tainted individuals. WHO revealed information
that incidence of HCV infectivity is 2.2% and every
year one million fresh cases were registered. In
addition 25% of hepatocellular carcinoma and 27%
of cirrhosis occurred in HCV trained persons. Such
virus increase extremely along with the creating
people particularly at those classifications that were
at the risk of danger of HCV [9].
In the world 200 million people are HCV patients
and among them 85% may create never ending
hepatitis or hepatocellular carcinoma. In developing
countries like Pakistan HCV is rapidly rising medical
problem. Its frequency is 10% and the most common
genotype is 3a. About 80% of contamination
prolongs to permanent disease and infected blood is
the major cause of spread of disease. About 75% of
the licenses do not get typical standard for HCV
treatment in Pakistan (Ribavirin+interferon) and of
the 25% that obtain such cure the SVR rate is 60 -
70% [10].
EPIDEMIOLOGY
Around the world it has been determined that 130 -
170 million people are contaminated with HCV,
occurrence of disease assessed at 2 to 3%. HCV
incidence is a highly challengeable among nations
and between age and risk bunch inside the nations.
This can be a bit explain by the usual for the
investigated population and crucial technique of
transmission [11]. Every year in the world about a
quarter of a million deaths occur because of chronic
liver infections linked with HCV [12]. Africa,
Eastern Mediterranean, South East Asia were highly
prevailed while North America, northern and western
and Australia bringing down the frequency of the
disease [13].
Page 1886
 IAJPS 2018, 05 (03), 1885-1897
The average for an area as opposed to particular
nation local evaluation extend from <10 in Europe to
>2.9% in Northern Africa. U.K and Scandinavia have
been accounted most reduced rate of prevalence
(0.01- to 0.1), While Egypt have highly elevated
prevalence (15% to 20%). It is expected that 25% of
hepatocellular carcinoma and 27% of cirrhosis is
occurred in HCV tainted people [14]. In Egypt the
velocity of HCC is rising wherever the chief hazard
aspects are chronic contamination with HBV and
HCV. A chief part of the populace is engaged in
agriculture, elevate the opportunities that an
additional danger factor for HCC is experience to bug
killer (Sameera Ezzat et, al international Journal of
Hygiene and Environmental Health 2005)
. A number of countries have considerable account of
HCV infection: in Egypt 15 to 20% while in Pakistan
10% of the population is infected [15]. There is a
wide range of the HCV infection is observed in
Pakistan. Different regions, their religious and social
behavior of a public play an important role in the
increasing frequency of the geological
prevalence..Broken infusion, unhygienic conditions
and misrepresentation are the main etiological
elements to spread the disease [16]. In current
situation in Pakistan roughly 10 million people are
suffering with HCV, covered about 6% of the
population of the country and it falls in widespread
zone. The reasons for this high rate of prevalence is
because of bad prevention procedures, lacking
finance for medical services, a massive increase in
work load and deficient arrangement of boundary
tools for health care workers. In addition society put
them at a high risk of gaining HCV infection [17].
Unfortunately in our country no national knowledge
is gathered for the assessment of disease and their
association with genotype or no statistical
information is available about patients. The second
biggest city of Pakistan that is Lahore\have more than
7 million populations. Information is exclusively
known with HCV genotype specially prevalence and
way of this infection is limited in this city [18]. In
spite of actuality that in different crowd of alike
group. The closeness of HCV infection among
www.iajps.com
Sheikh Ahmed et al ISSN 2349-7750
different classes was in Islamabad(5.31%), 1.1-9% in
KPK, In different regions of Punjab it was 0.4-
31.9%, 1.5% in Quetta, 4-6% in Sindh, 25.7% within
Gilgit Baltitistan, whereas in Lahore the incidence of
infection was 0.58-17.78% [19].
A current study investigated that among Central and
South America in San Juan, peurto Rico verified that
in 2001 to 2002 the frequency of HCV was 6.3%. It
was showed around 2.1% in Mexico. In chile and
Brazil the rate of occurrence was low0.3%, 1.14%
individually with in the blood donors [20]. Studies
relating with the spread of HCV are very few at
different ages and they express defensive as well as
temporary varieties that reveal periods of
transmission of HCV prolonged risk in each region
three distinctive epidemiological examples are
observed in these studies [21]. Blood is regularly
screened for HCV and procedures are established to
control disease and safe infusion practices are
available in developed countries. At present HCV is
passing on through the use of infusion medicate.
While in developing countries use of infusion sedate,
similarly in can be an important risk factor for the
transmission of HCV. In this planet China has
surprising increased number of HCV contaminated
infusion medicate clients (IDUs). In Pakistan,
Mexico and Thailand >80 of IDUs are antagonistic to
HCV positive [22].
In 1990 when HCV screening was presented in US
the rate of hepatitis post transmission was fall from
3.84% to 0.57%. In England the reappearance of
HCV infection falls from 1 out of 520000 to 1 out of
30 million in 1999 to 2001. while contributions were
tried for HCV RNA [20]. In many countries
economic weight of HCV have not been clear.
wherever the research of transmission of HCV have
been considered result of never ending HCV and
liver cirrhosis and carcinoma take in to sight to
progressively more outcome on public fitness
framework. fresh infection still occur due to use of
unscreened blood transfusion, the incapability to
sanitize curative equipment adequately and the
development in intravenous drug use in previously
unaffected region [23].
Page 1887
 IAJPS 2018, 05 (03), 1885-1897 Sheikh Ahmed et al ISSN 2349-7750

(Wong & Lee, 2006).

universal occurrence of constant hepatitis C virus contamination (reprinted from Holmberg S (Averhoff et al., 2012).
The learning of HCV epidemiology acts a vital job in
the techniques of its avoidance. HCV subtypes/ are
clinically extremely significant as diverse subtypes
are related toward epidemiological problem, vaccine
growth, and medical administration of persistent
HCV contamination [24]. Currently HCV is classify
into 7 genotypes scheduled combination of viral
genome, every one vary at 30 to 35% of nucleotide
locals and in to 67 confirmed while 20 subtypes are
temporary distinct at <15% of nucleotide intention
[25]. Throughout the world genotype 1,2 and 3 are
usually distributed and their comparative frequency
alter starting with one geographic region to the next.
Genotypes 4, 5 and 6 are exposed only in specific
regions. In USA, Japan and Europe subtype 1a and
1b are distinguished genotypes, while in Pakistan
and India 3a is the highly prevailed[24].
GENOMIC ORGANIZATION OF HCV
It is a positive RNA germ in the company of a
genome includes about 9500 nucleotides. It have an
unlock interpretation structure that codes a huge

www.iajps.com Page 1888

 IAJPS 2018, 05 (03), 1885-1897
polyprotein of concerning amino acids about 30000.
after slice by host and viral enzymes this polyprotein
bring into being polypeptides around 10 [1]. RNA
positive strand genome to is collected at NCR a 5′-
non-coding region , which contain an (IRES), that is
interior ribosome entry site, an unlock reading
structure to code a 3′-NCR and structural as well as
non-structural proteins [26]. A study of the chain
surrounded by the 5′ UTR from 39 dissimilar
segregate and HCV genotypes illustrate notable chain
protection.46 This section be the mainly preserved of
the genome, a distinguishing permit it to utilize as a
analytical locus genotype and indicator (HCV RNA)
through PCR .47 surrounded by this area, the bulk of
HCV genotypes acquire a transformation beginning
locus strongly like other RNA viruses, the same as
influenza as well as polio [27]. In the 5’ portion of
the genome the genes designed for structural
proteins E1 and E2 , C (core), and perhaps p7, are
located [28]. First third of the polyprotein encode the
viral structural proteins and contain interior or capsid
protein (C) and the cover glycoprotein’s p7, E1 and
E2. and nonstructural proteins, programmed via the
C-terminal two-thirds of the polyprotein, take part in
diverse function in virus gathering and replication of
RNA [29]. The major function of C protein is
supposed to exist the creation of viral capsid,
although the appearance of this protein have been
account to contain pleiotropic special effects in
mammalian cells, with transcriptional tone,
modification of the lipid metabolism and sound
effects on apoptosis[30]. E1 and E2 are chief viral
glycoprotein’s, out as of the viral polyprotein by the
stroke of host-cell indication peptidases. Examination
of the amino termini of mutually E1 (gp35) and E2
(gp70) show that they are slice at amino acids 383
along with 746 correspondingly. equally proteins are
deeply glycosylated amid 5}6 plus 11 N-linked
glycosylation location correspondingly moreover E2
is occasionally originate total at its carboxy terminus
toward take account of a minor protein recognized as
p7 like that several E2 type be able to observed later
than appearance within eukaryotic organism [31].
The 3' code section code for the enzymatic or non
structural protein: Protein NS2 (p23) subsist a
metalloprotease concerned in NS2-NS3 slash; a
serine-protease Protein NS3 (p72) is accountable
designed for slice between NS3 plus NS4a, NS4a
plus NS4b, NS4b and NS5a, and NS5a as well as
NS5b; it in addition have a helicase action essential
on behalf of viral RNA duplication. similar to the
capsid protein, it is the most important viral antigens
is broadly applied for serological analysis 32]. For
RNA replication and packaging the 3' UTR is
considered to be important and has been bring into
www.iajps.com
Sheikh Ahmed et al ISSN 2349-7750
being important for contamination of cDNAs HCV
[33].
The NS2 protein have been exposed to be there a
transmembrane protein among its carboxy terminus
translocated addicted to the lumen of the ER whereas
its amino terminus lie down in the cytosol. though
immunoprecipitation reading have revealed that NS2
is strongly linked among the structural proteins the
natural purpose of the greater part of the NS2 protein
is not yet distinct [31].
NS3 have two functional particle transport, within the
amino-terminal C180 residue, a serine-type
proteinase in charge for cut at the NS3}4A and
NS4A}B, NS4B}5A plus NS5A}B place in the
carboxy-terminal residue, NTPase}helicase actions
crucial for replication as well as translation of the
genome of HCV [34]. The N-terminal area of NS3
jointly among the tiny NS4A peptide make up the
NS3-4A protease, a distinctive serine protease that
slice the polyprotein at the NS3/NS4A, NS4A/NS4B,
NS4B/NS5A as well as NS5A/NS5B connection. The
C-terminal area of NS3 hold an NTPase/helicase
required in favor of replication as well as translation
of the genome of HCV [35]. NS4B is a fundamental
covering protein hold a nucleotide obligatory sphere
inside its cytosolic area. NS4B appearance within
cells of mammalian bring distinguishing membranous
vesicles - the covering web - which are supposed to
subsist the place of duplication of virus [30].
NS5A protein restrict inside the nuclear periplasmic
covering portion. Current researches have
recommended that the carboxy terminus of HCV
NS5A protein with its two third part role as a
transcriptional trigger in mammalian and yeast cells
within the perspective of the GAL4 arrangement. On
the other hand, the NS5A protein with the full length
does not involve an end product in a related trial
structure. the outcome of NS5A taking place the
dangerous gears [p21WAF", p53 along with
proliferating cell nuclear antigen (PCNA)] also
concerned in cell phase parameter and its
responsibility of the development of murine
fibroblast according to rule [36].
Proofreading skills are not found in NS5B, and this
direct to a elevated transformation velocity and the
production of various quasispecies. HCV segregate
mainly be able to grouped into 7 genotypes, which
differ within chain extra than 30%. In adding to the
diverse pervasiveness with worldwide increase of the
disease, the genotype be a significant feature
formative disease development and reaction to
treatment against virus [37].
Page 1889
 IAJPS 2018, 05 (03), 1885-1897
The characteristics of HCV genome association are
like near those of other pestiviruses plus flaviviruses
within the family Flaviviridae. Consequently, HCV
was categorized as a split group, Hepacivirus, of the
Flaviviridae family series investigation as well as
Genome of HCV union. (A) The single-strip RNA
genome codes a extended open perusing outline
(ORF) border via 2 UTRs, which include indicator in
favor of viral protein with RNA incorporation and the
organization of the two actions. Analysis is in
progress through (IRES) an inward ribosomal
passage site in the 5' UTR. C, cytidine U, uridine;.
(B) The read polyprotein is posttranslationally plus
cotranslationally arranged via viral proteases and cell.
Figures beneath the polyprotein illustrate the amino
corrosive spaces of the cleavage end. (C) A role of
the consequent nonstructural and 10 auxiliary
proteins a frame shift (F) protein is decoded from a
small interchange perusing outline (ARF). stature
changed among authorization commencing (S23)
Nature Reviews Immunology [38].
LIFE CYCLE
The life rotation of HCV is completely
cytoplasmic. Duplication occurs all the way
throughout a tiny strand intermediary inside a cover
restricted separation; give in double stranded RNA
(dsRNA) intermediates. The duplicative
www.iajps.com
Sheikh Ahmed et al ISSN 2349-7750
evaluation reading exposed with the aim of together
the 5’UTR with 3’UTR of HCV genome are
extremely preserved. during a quick compare, series
of the ORF display a notable distinction
(quasispecies) amid different isolates of HCV[28].
intermediates are wholly accessible in the direction
of the cell dsRNA-detecting hardware and prompt
solid natural cell response following infection
(Chisari, 2005)[39] Infectivity begin by joining
together to have cell receptors and jamming molecule
cover gives an tempting focal point to cooperative
mediation. HCV is a cover positive-stranded RNA
virus that codes E1 and E2 two
glycoprotein’s(GPS),, together are fundamental for
molecule segment[40].
It have a positive-strand RNA genome weighting
about 9.6 kb prepared out of a 5' NCR which
integrate an inner ribosome passage site (IRES), a
extensive unlock perusing outline programming a
polyprotein predecessor a 3' NCR and around 3,000
amino acids. The polyprotein predecessor is co-and
post-translationally hold through viral proteases and
cell to the extend nonstructural and auxiliary protein
[26]. The HCV 5' UTR hold an extremely ordered
and the 3' UTR and internal ribosome entrance site, is
crucial for copying [41]. It is obvious that
nonstructural proteins NS3 to 5B are obligatory as
well as adequate for HCV RNA duplication. They
Page 1890
 IAJPS 2018, 05 (03), 1885-1897
construct a multiprotein compound that in similarity
to supplementary positive-strand RNA germ is
connected among intracellular membranes [42].
Diverse passage factors and cell receptors for HCV
have been known, as well as the hunter receptor
CD8147 and class B write I (SRB1), in addition firm
junction proteins, claudin-1 (CLDN1 and occludin
(OCLN).) further as of late illustrious segment
feature fit in the receptor tyrosine kinases (RTK)
ephrin receptor A2 (EphA2) epidermal growth
feature receptor (EGFR), Niemann-Pick C1-like 1
cholesterol retention receptor (NPC1L1) are
accounted for [35]. After access into the cell
attachment is followed, the uncoated virus, revealing
the positive-strand RNA genome. post conversion, a
solitary bulky polyprotein is formed, which is in the
direction of be sliced into nonstructural and structural
protein The positive-strand RNA supply the same as
a model to produce a RNA negative strand which
attach near the NS proteins structure a replicating
compound create more RNA positive strand [43].
The molecular characteristics that control RNA
duplication and viral conversion are unidentified.
Study among poliovirus, the prototype (+)-strand
RNA virus, illustrate that transformation plus RNA
imitation are commonly limited procedure. Other
information acquire with flaviviruses Kunj in West
Nile with poliovirus the Dengue proposed that the
viral RNAs from a globular construction that ropes
the organization of RNA production and protein of
virus [44]. The two envelope proteins E1 and E2 and
nucleocapsid protein core shape the N terminus of the
polyprotein along with athe formation machinery of
HCV virions. The predecessor also increase to six
non-structural (NS) proteins and the viroporin p7
concerned in polyprotein processing, viral RNA
duplication, and contagious virion construction: the
RNA helicase, NS2-3 auto protease, its cofactor
NS4A the NS4B and NS5A proteins, NS3 serine
protease, as well as the NS5B RNA-dependent RNA
polymerase [45].
HCV proteins are produced through IRES-mediated
conversion of the genome. Transformation occurs in
the R.E.R wherever host cell indicate peptidase,
indicate peptide peptidase, in addition to mainly
estimated the viral proteases speed up the slicing of
the polyprotein. development of the vesicles of
membranes that mount up in the direction of structure
a "membranous web" is persuade through NS4B
possibly in performance with viral (e.g. NS5A) plus
host cell feature (e.g. VAP or FBL2). NS5B most
probably in collaboration with supplementary viral
(e.g. NS3/4A, NS5A) and host cell feature gather at
www.iajps.com
Sheikh Ahmed et al ISSN 2349-7750
the 3closing stages of RNA positive strand to start de
novo production [46].
The recently manufactured positive-strand RNAs,
which are copied from RNA negative strand
intermediates, act as model for the conversion of
RNA or for the synthesis of RNA negative strand. on
the other hand, positive-strand descendant is utilize
for the get-together of contagious virus element
through a procedure to facilitate firmly associated to
cytosolic droplets of lipid with the very-low-density
lipoprotein (VLDL) path [47]. The actions of
molecule that occurs at some stage in get-together of
contagious particles of HCV with the interaction
among host plus viral aspects are now being exposed.
It is assumed that HCV get-together subsists begin
within secure immediacy toward intracellular lipid
droplet (LD) formation resting on the exterior of
which the core capsid of viral protein builds up.
moreover to viral feature, numerous host features
contribute in HCV constituent part congress and
envelopment[48]. yet, the molecular information of
viral get-together, established, and discharge stay to
be definite [45].
Figure 1
Diagrammatic illustration of the life cycle of HCV.
each pace of the life series propose a diversity of
latent objective for original curative [35].
TREATMENT
For viral duplication the enzyme HCV-encoded
NS3 protease is key and has been seen as a
connecting application for therapeutic interference
in HCV-spoiled persons [49]. boceprevir (BOC)
and telaprevir (TPV), two inhibitors of
nonstructural 3/4A viral protease, proficient the
market, altering the standard of administer to the
Page 1891
 IAJPS 2018, 05 (03), 1885-1897
cure of ceaseless HCV to triple healing with an
HCV protease inhibitor , Pegylated interferon-alpha
(Peg-IFNa),and ribavirin (RBV),These managers
enhance the charge of upheld virologic response
(SVR) in medication of people by 30% while
supplementary to RBVI-3 plus Peg-IFN in addition
to propose an additional healing optional for people
who unsuccessful precedent treatment [50].
The current progress of small molecule annoy that
immediately impede the viral life cycle deal with a
significant important instant for the management of
perpetual hepatitis C infection (HCV). These latest
drugs that are well thought-out facilitate acting
against viruses (DAA) join an degree of inhibitors of
the non-structural (NS) 3/4A protease and NS5B
polymerase, along with NS5A protein [51].
To get administrative hold up telaprevir and
Boceprevir were the key DAAs. .accurately when
connected with ribavirin, and PEG-IFN these
administrator boost charge of strengthen virologic
reaction in HCV genotype 1 to ∼70%. This course
of therapy is associated with a team of toxicities.
In resembling method, both telaprevir and
boceprevir are substrates inhibitors of the
recommended carrier the cytochrome P450 and P-
glycoprotein drive 3A4 and next to these position,
biased to clinically serious medicine association
[52].
In May 2011, the telaprevir, and boceprevir two
distinctive NS3/4A protease inhibitors, were being
adamant in the mixture with RBV and PEG-IFN for
24-48 weeks in HCV genotype 1 pollutions.
Simeprevir, a tiny mature NS3/4A protease
inhibitor, be emphasize for utilize with PEG-IFN
plus RBV designed for 12 weeks in genotype
1(December 2013,) whereas an NS5B nucleotide
polymerase inhibitor sofosbuvir, ,was squeeze for
apply for genotypes 1 as well as 4 among RBV and
PEG-IFN for 12 weeks, in addition among RBV in
genotype 2 only for 12 weeks and genotype 3 for
weeks around 24 [53].
In this point 3 trials integrating people suffering by
means of genotype 2 or 3 HCV disease, cure with
ribavirin -sofosbuvir for twelve weeks understand
charge of augment virologic reaction of 67% amid
person who have inexperienced precedent
interferon-based healing in addition to 78% with
people for whom peg interferon cure was
unworkable due to contraindications [54]. As of
delayed produced interferon PEG-IFN alpha-2b,
Pegylated IFNs (PEG-IFNs), and PEGIFN alpha-
2a, encompass transport regarding enhanced
effectiveness. In some case, the control virological
www.iajps.com
Sheikh Ahmed et al ISSN 2349-7750
answer velocity for tainted people spoiled with
genotype 1 HCV with elevated accepted weight, for
the largest part extensively familiar profile in this
state, stays under half [55].
Antiviral medication with interferon has
encouraged covering of HCV-impelled damage to
lever in patients with elevated ALT height and
continuous hepatitis, aggravating a reserved
virological reaction in about 20% of cases. It isn't
in no doubt whether interferon oppress HCV RNA
in the entire agreement in transporters with
persistently usual ALT regards [56]. Peg interferon
support medication is associated with clinically
massive introductory proceedings, with influenzas
like sign and debilitation. fundamentals include
patients' race,age,IL28B genotype, HCV genotype,
stage of liver fibrosis, HCV viral weight at a check,
have been appeared to force the reaction to peg
interferon-based cure and different drugs being
created [57].
Cure with ribavirin and peg interferon is related
with diverse unfriendly effects. The majority of
patients encountering healing practice side effects
from soft to indisputable. Consequently, peaceful
arrangement of potential reaction and month to
month appointment for surveillance blood test and
response should be highlight prior to the
commencement of treatment. The most commonly
professed signal of peg interferon are reduction,
muscle problems and cerebral responses, for
occasion, depression, anxiety, rest troublesome
impact and irascibility (Modi & Liang, 2008). A
team of DAAs preliminary at now in late-orchestrate
medical examination, counting NS5A inhibitors,
NS5B polymerase inhibitors (equally nucleoside plus
non-nucleoside) NS3/NS4A serine PIs, as well as
cyclophilin inhibitors, together among and lacking of
RBV and peg-IFN, are capable for the HCV cure
[58].
Daclatasvir is a remarkably first class exacting
NS5A HCV duplication compound inhibitor among
picomolar excellence outside a living organism.
Asunaprevir is an unusually dominant HCV NS3
protease inhibitor. together daclatasvir and
asunaprevir pass on strong abatements in HCV RNA
height in patients in the company of HCV genotype 1
problem, and connection of the two drugs in the mix
did not create a clinically notable pharmacokinetic
relationship[59]. Another HCV NS5A inhibitor is
Ledipasvir (Gilead Sciences) is with solid antiviral
expansion in opposition to genotypes of HCV 1a and
1b.11 In systematize 2 experiments, the mix of
sofosbuvir, ledipasvir with and with no ribavirin,
recognize elevated charge of reinforce virologic
Page 1892
 IAJPS 2018, 05 (03), 1885-1897
reaction amid person suffering with HCV genotype 1
contamination who had turn into previous to cure
with interferon-based course of therapy, counting
people who have gotten a protease-inhibitor course of
therapy furthermore persons with remunerated
cirrhosis[60].
Velpatasvir beforehand GS-5816, Gilead Sciences is
a fresh pan-genotypic NS5A HCV inhibitor among
action against virus in opposition to HCV duplication
within genotypes 1 through 6. In systematize 2
checks, the mingle of 100 mg of velpatasvir and 400
mg of sofosbuvir with or with no ribavirin attained
elevated charge of reserved the virologic reaction in
an extensive degree of persons with HCV [61].
For people who are near the beginning at now
introduce illegal meds or intake over the paramount
measures of alcohol, Treatment of HCV with
interferon alfa and ribavirin is not suggested in light
of the manner that the stability of the IDUs is
deprived and the danger of reinfection elevated if
they persist infusing medicine [62].
PREVENTION
The transmission route of HCV demonstrate in the
text are tissue and organ, blood, blood products,
insecure health procedure; healthcare contact e.g.
needle bond wound, use of intravenous drug, sexual
spread, vertical transmission and body piercings [63].
Epidemiology of hepatitis and its routes of
transmission have been altered through the precedent
age of 18. since the HCV test examination sensitivity
had improved, latest viral disease contagious via
blood products have been almost eradicate in
urbanized states and had reduced in rising nations
[64].
Several people with continual HCV contamination
may have obtained their disease 20 to 30 years ago as
an outcome of restricted or infrequent unlawful
medicine insert. Injecting-drug utilize go ahead to
transmission of HCV in a method like to that for
other blood-borne disease causing agents (i.e., during
a transmit of HCV-infected blood by reuse of needle
either directly or through infectivity of drug
grounding apparatus [65]. occurrence of viremia
motherly HCV is a dangerous issue in mother-on the
way to-child conduction of HCV. Maternal co-
infection HIV is a vital hazard feature. In offspring
born to viremic HCV female, the chances of disease
were set up to be among 1.97 and 2.82 superior than
individuals born to positive HIV- contrast among
negative HIV mother [66].
The function of sexual action in the HCV spread is
still blurred. ≤20% of patients amid HCV infectivity
www.iajps.com
Sheikh Ahmed et al ISSN 2349-7750
account sexual experience (i.e., introduction to a
contaminated sexual spouse otherwise too many
associates) in the deficiency of percutaneous hazard
aspects. Further identified exposure (professional,
hemodialysis, domestic, perinatal) jointly explanation
for around 10% of disease. therefore, a potential
threat factor can be recognized for about 90% of
people with HCV contamination [21].
ELISA (Enzyme-linked immunosorbent assay), PCR
polymerase chain reaction) as well as recombinant
immunoblot assay (RIBA), are a few laboratory
methods for the detection of HCV. Usually, as
screening tool ELISA is applied, for complementary
test the application of RIBA is suitable and for
confirmation PCR is used. HCV antibody finding
with ELISA has a low specific rate and positive
prognostic assessment for low-risk grouping such as
blood giver and the common inhabitants (Alavian et
al., 2009). The analyses of the outcome of serologic
examination depend on the theme threat of
contribution. In the low-risk populace, such as blood
donor or common people, an incidence of fake
positive outcome of EIA-2 are extremely elevated 40
to 50% contrast among RIBA-2, whereas in a high -
danger populace, like recommendation laboratories,
EIA-2 have fake positive smaller amount than 1%.
Antibody viewing test be the main experiment for
detect anti HCV, along with for a positive test
examination, a further precise supplemental analyze
is required. though, these figures show that
supplemental anti-HCV investigation is usually not
crucial in high threat people amid a anti-HCV
positive screen check [67].
Qualitative recognition tests are stand on the standard
of intention intensification by means of either TMA.
Or "classic" polymerase chain reaction (PCR), "real-
time" PCR. RNA from HCV is take out moreover
overturn transcribed into cDNA double strand [68]. If
the load of HCV are to be diminished than at national
and global level HCV conservation programmers are
required [23].
An essential factor of Prevention is concern and
ought to aim together HCV-contaminated person and
those at danger but not contaminated yet Citizens
who are not infected be capable of be recommended
to avoid obtain the disease. individuals who are
contaminated can keep away from dangerous live out
related with infection Safety measures in the centers
for hemodialysis are extra accurate than usual safety
measures. While people or hemodialysis apparatus is
handled, utilize of gloves is suggested, yet there is no
blood, discharge and infected solution. Provisions,
apparatus, as well as medicine for every patient ought
Page 1893
 IAJPS 2018, 05 (03), 1885-1897
to not divide with others. hygienic in addition to
polluted piece ought to be alienated [67].
Primary prevention of HCV infection has been on
concentration in some countries via application of
insertion practices and protected transfusion , lesser
avoidance of morbidity as well as death from HCV
contamination by the aid of interferon-based
treatment to unhygienic person is a rational public-
health essential [69]. Finding and handling of
diseases in before time period are included in
secondary prevention previous to roots considerable
morbidity. HCV antivirus management, in spite of
the genotype ,of HCV age of patient, plus co
morbidities consequences in Sustained Virologic
Response (SVR) in several person that show the way
to enhanced continued existence and condensed liver-
related and all-cause death (Shalmani et al., 2013).
For complete health agenda concern for hepatitis C is
a very important factor. Such concern consist of
screening for spread hazard behavior, testing for
HCV antibody and RNA, prevention psychotherapy
and education, immunization against HAV plus
HBV, moreover assessment for co-morbidities,
together with HIV infectivity[70].
CONCLUSIONS:
It is estimated that approximately ten million persons
in Pakistan (6% of the public) have been suffering
with HCV infectivity. The prevalence rate is elevated
among fairly aged populace and patients receiving
hemodialysis or who got a blood transfusion prior to
the upcoming of HCV analytical apparatus. Pakistan
is pandemic for HCV due to the lack of education
and awareness with the virus, insufficiency of
therapeutically skilled and reasonably organized
community assurance authorities and lack of health
institutions. This increase in HCV is full with the
elevated numbers of useful infusions use and day by
day face and armpit shave in crowd hairstyling
beauty salons. The growing HCV virulent disease is
most likely going to progress to a major rise in
difficulty weight over the upcoming years. A
multidisciplinary approach will be predictable to
obtain suitable particular procedure, increase
mindfulness together lay and therapeutic cluster, and
carry further feasible distinctive confirmation and
management of HCV infected people.
REFERENCES:
1. Lyra, A. C., Fan, X., & Di Bisceglie, A. Molecular
biology and clinical implication of hepatitis C
virus. Brazilian Journal of Medical and
Biological Research,2004; 37(5): 691-695.
www.iajps.com
Sheikh Ahmed et al ISSN 2349-7750
2. Moradpour, D., Penin, F., & Rice, C. M.
Replication of hepatitis C virus. Nature Reviews
Microbiology, 2007;5(6): 453.
3. Berenguer, M. (2002). Natural history of recurrent
hepatitis C. Liver Transplantation, 8(10B).
4. Firpi, R. J., Clark, V., Soldevila‐Pico, C., Morelli,
G., Cabrera, R., Levy, C., . . . Nelson, D. R. The
natural history of hepatitis C cirrhosis after liver
transplantation. Liver Transplantation,2009;
15(9): 1063-1071.
5. Bruno, S., & Facciotto, C. The natural course of
HCV infection and the need for treatment. Ann
Hepatol, 2008;7(2): 114-119.
6. Alberti, A., Vario, A., Ferrari, A., & Pistis, R.
chronic hepatitis C–natural history and cofactors.
Alimentary pharmacology & therapeutics,2005;
22(s2): 74-78.
7. Marascio, N., Liberto, M. C., Barreca, G. S., Zicca,
E., Quirino, A., Lamberti, A. G., . . . Berardelli,
G. Update on epidemiology of HCV in Italy:
focus on the Calabria Region. BMC infectious
diseases,2014; 14(5): S2.
8. Berenguer, M., Prieto, M., Rayón, J. M., Mora, J.,
Pastor, M., Ortiz, V., . . . Mir, J. Natural history
of clinically compensated hepatitis C virus–
related graft cirrhosis after liver transplantation.
Hepatology, 2000;32(4): 852-858.
9. Daw, M. A., & Dau, A. A. (2012). Hepatitis C
virus in Arab world: a state of concern. The
Scientific World Journal, 2012.
10. Akbar, H., Idrees, M., Manzoor, S., Ur Rehman,
I., Butt, S., Yousaf, M., . . . Akram, M. Hepatitis
C virus infection: A review of the current and
future aspects and concerns in Pakistan. Journal
of General and Molecular Virology,2009; 1(2),
012-018.
11. Ansaldi, F., Orsi, A., Sticchi, L., Bruzzone, B., &
Icardi, G. Hepatitis C virus in the new era:
perspectives in epidemiology, prevention,
diagnostics and predictors of response to
therapy. World journal of gastroenterology:
WJG, 2014;20(29): 9633.
12. Raja, N. S., & Janjua, K. A. Epidemiology of
hepatitis C virus infection in Pakistan. Journal of
Microbiology Immunology and Infection,2008;
41(1:, 4.
13. Lee, M.-H., Yang, H.-I., Yuan, Y., L’Italien, G.,
& Chen, C.-J. Epidemiology and natural history
of hepatitis C virus infection. World journal of
gastroenterology: WJG, 2014;20(28): 9270.
14. Alter, M. J. Epidemiology of hepatitis C virus
infection. World journal of gastroenterology:
WJG2007; 13(17): 2436.
15. Wong, T., & Lee, S. S. Hepatitis C: a review for
primary care physicians. Canadian Medical
Association Journal, 2006;174(5): 649-659.
Page 1894
 IAJPS 2018, 05 (03), 1885-1897
16. Zuberi, S. J. Seroepidemiology of HBV/HCV in
Pakistan. International Hepatology
Communications, 1996;5(1): 19-26.
17. Khan, S., Attaullah, S., Ayaz, S., Khan, S. N.,
Shams, S., Ali, I., . . . Siraj, S. Molecular
epidemiology of HCV among health care
workers of Khyber Pakhtunkhwa. Virology
journal,2011; 8(1): 105.
18. Ahmad, W., Ijaz, B., Javed, F. T., Jahan, S.,
Shahid, I., Khan, F. M., & Hassan, S. HCV
genotype distribution and possible transmission
risks in Lahore, Pakistan. World journal of
gastroenterology: WJG, 2010;16(34): 4321.
19. Anwar, M. I., Rahman, M., Hassan, M. U., &
Iqbal, M.Prevalence of active hepatitis C virus
infections among general public of Lahore,
Pakistan. Virology journal2013; 10(1): 351.
20. Sy, T., & Jamal, M. M. Epidemiology of hepatitis
C virus (HCV) infection. International journal of
medical sciences, 2006;3(2): 41.
21. Alter, M. J., & Margolis, H. S. (1998).
Recommendations for prevention and control of
hepatitis C virus (HCV) infection and HCV-
related chronic disease.
22. Averhoff, F. M., Glass, N., & Holtzman, D.
Global burden of hepatitis C: considerations for
healthcare providers in the United States.
Clinical infectious diseases, 2012;55(suppl_1):
S10-S15.
23. Lavanchy, D. Evolving epidemiology of hepatitis
C virus. Clinical Microbiology and Infection,
2011;17(2): 107-115.
24. Yan, Z., Fan, K., Wang, Y., Fan, Y., Tan, Z., &
Deng, G. Changing pattern of clinical
epidemiology on hepatitis C virus infection in
southwest china. Hepatitis monthly, 2012;12(3):
196.
25. Petruzziello, A., Marigliano, S., Loquercio, G.,
Cozzolino, A., & Cacciapuoti, C. Global
epidemiology of hepatitis C virus infection: An
up-date of the distribution and circulation of
hepatitis C virus genotypes. World journal of
gastroenterology,2016; 22(34): 7824.
26. Moradpour, D., Brass, V., Gosert, R., Wölk, B.,
& Blum, H. E. Hepatitis C: molecular virology
and antiviral targets. Trends in molecular
medicine, 2002;8(10): 476-482.
27. Drazan, K. Molecular biology of hepatitis C
infection. Liver Transplantation,2000; 6(4): 396-
406.
28. Luo, G. (2004). Molecular virology of hepatitis C
virus Hepatitis prevention and treatment (pp. 67-
85): Springer.
29. Catanese, M. T., Uryu, K., Kopp, M., Edwards,
T. J., Andrus, L., Rice, W. J., . . . Rice, C. M.
Ultrastructural analysis of hepatitis C virus
www.iajps.com
Sheikh Ahmed et al ISSN 2349-7750
particles. Proceedings of the National Academy
of Sciences,2013; 110(23): 9505-9510.
30. Tomei, L., Altamura, S., Paonessa, G., De
Francesco, R., & Migliaccio, G. Review HCV
Antiviral Resistance: The Impact of in vitro
Studies on the Development of Antiviral Agents
Targeting the Viral NS5B Polymerase. Antiviral
chemistry and chemotherapy,2005; 16(4), 225-
245.
31. Clarke, B. Molecular virology of hepatitis C
virus. Journal of General Virology,1997; 78(10):
2397-2410.
32. Pozzetto, B., Bourlet, T., Grattard, F., &
Bonnevial, L. Structure, genomic organization,
replication and variability of hepatitis C virus.
Nephrology Dialysis Transplantation,1996;
11(supp4): 2-5.
33. Irshad, M., & Dhar, I. Hepatitis C virus core
protein: an update on its molecular biology,
cellular functions and clinical implications.
Medical principles and practice, 2006;15(6):
405-416.
34. Bartenschlager, R., & Lohmann, V. Replication
of hepatitis C virus. Journal of General
Virology, 2000;81(7), 1631-1648.
35. Kim, C. W., & Chang, K.-M. Hepatitis C virus:
virology and life cycle. Clinical and molecular
hepatology, 2013;19(1): 17.
36. Ghosh, A. K., Steele, R., Meyer, K., Ray, R., &
Ray, R. B. Hepatitis C virus NS5A protein
modulates cell cycle regulatory genes and
promotes cell growth. Journal of General
Virology,1999; 80(5): 1179-1183.
37. Boonstra, A., van der Laan, L. J., Vanwolleghem,
T., & Janssen, H. L. Experimental models for
hepatitis C viral infection. Hepatology,
2009;50(5): 1646-1655.
38. Rehermann, B. Hepatitis C virus versus innate
and adaptive immune responses: a tale of
coevolution and coexistence. The Journal of
clinical investigation,2009; 119(7): 1745-1754.
39. Chisari, F. V. Unscrambling hepatitis C virus–
host interactions. Nature, 2005;436(7053): 930.
40. Lemon, S. M., McKeating, J. A., Pietschmann,
T., Frick, D. N., Glenn, J. S., Tellinghuisen, T.
L., . . . Furman, P. A. Development of novel
therapies for hepatitis C. Antiviral
research,2010; 86(1): 79-92.
41. Kapadia, S. B., & Chisari, F. V. Hepatitis C virus
RNA replication is regulated by host
geranylgeranylation and fatty acids. Proceedings
of the National Academy of Sciences of the
United States of America, 2005;102(7): 2561-
2566.
42. Quinkert, D., Bartenschlager, R., & Lohmann, V.
Quantitative analysis of the hepatitis C virus
Page 1895
 IAJPS 2018, 05 (03), 1885-1897
replication complex. Journal of virology,
2005;79(21):13594-13605.
43. Szabó, E., Lotz, G., Páska, C., Kiss, A., & Schaff,
Z. Viral hepatitis: new data on hepatitis C
infection. Pathology & Oncology Research,
2003;9(4): 215.
44. Isken, O., Baroth, M., Grassmann, C. W.,
Weinlich, S., Ostareck, D. H., Ostareck-Lederer,
A., & Behrens, S.-E. Nuclear factors are
involved in hepatitis C virus RNA replication.
Rna, 2007;13(10): 1675-1692.
45. Herker, E., & Ott, M. Unique ties between
hepatitis C virus replication and intracellular
lipids. Trends in Endocrinology & Metabolism,
2011;22(6):241-248.
46. Appel, N., Schaller, T., Penin, F., &
Bartenschlager, R. From structure to function:
new insights into hepatitis C virus RNA
replication. Journal of Biological Chemistry,
2006;281(15): 9833-9836.
47. Bühler, S., & Bartenschlager, R. New targets for
antiviral therapy of chronic hepatitis C. Liver
International, 2012;32(s1): 9-16.
48. Shulla, A., & Randall, G. Hepatitis C virus—host
interactions, replication, and viral assembly.
Current opinion in virology,2012; 2(6):725-732.
49. Lamarre, D., Anderson, P. C., Bailey, M.,
Beaulieu, P., Bolger, G., Bonneau, P., . . .
Cordingley, M. G. An NS3 protease inhibitor
with antiviral effects in humans infected with
hepatitis C virus. Nature, 2003;426(6963): 186.
50. Kiser, J. J., Burton, J. R., Anderson, P. L., &
Everson, G. T. Review and management of drug
interactions with boceprevir and telaprevir.
Hepatology, 2012;55(5): 1620-1628.
51. Vermehren, J., & Sarrazin, C. The role of
resistance in HCV treatment. Best practice &
research Clinical gastroenterology,2012; 26(4):
487-503.
52. Kiser, J. J., Burton Jr, J. R., & Everson, G. T.).
Drug–drug interactions during antiviral therapy
for chronic hepatitis C. Nature Reviews
Gastroenterology and Hepatology, 2013;10(10):
596.
53. Yau, A. H. L., & Yoshida, E. M. Hepatitis C
drugs: the end of the pegylated interferon era and
the emergence of all-oral, interferon-free
antiviral regimens: a concise review. Canadian
Journal of Gastroenterology and
Hepatology,2014; 28(8), 445-451.
54. Zeuzem, S., Dusheiko, G. M., Salupere, R.,
Mangia, A., Flisiak, R., Hyland, R. H., . . .
Symonds, W. T. Sofosbuvir and ribavirin in
HCV genotypes 2 and 3. New England Journal
of Medicine, 2014;370(21): 1993-2001
www.iajps.com
Sheikh Ahmed et al ISSN 2349-7750
55. He, X. S., Ji, X., Hale, M. B., Cheung, R.,
Ahmed, A., Guo, Y., . . . Risch, N. Global
transcriptional response to interferon is a
determinant of HCV treatment outcome and is
modified by race. Hepatology, 2006;44(2): 352-
359.
56. Sangiovanni, A., Morales, R., Spinzi, G., Rumi,
M., Casiraghi, A., Ceriani, R., . . . Tavani, E.
Interferon alfa treatment of HCV RNA carriers
with persistently normal transaminase levels: a
pilot randomized controlled study. Hepatology,
1998;27(3): 853-856.
57. Feld, J. J., Jacobson, I. M., Hézode, C., Asselah,
T., Ruane, P. J., Gruener, N., . . . Chan, H. L.
Sofosbuvir and velpatasvir for HCV genotype 1,
2, 4, 5, and 6 infection. New England Journal of
Medicine,2015; 373(27): 2599-2607.
58. Shah, N., Pierce, T., & Kowdley, K. V. Review
of direct-acting antiviral agents for the treatment
of chronic hepatitis C. Expert opinion on
investigational drugs, 2013;22(9): 1107-1121.
59. Lok, A. S., Gardiner, D. F., Lawitz, E., Martorell,
C., Everson, G. T., Ghalib, R., . . . Wind-Rotolo,
M. Preliminary study of two antiviral agents for
hepatitis C genotype 1. New England Journal of
Medicine, 2012;366(3): 216-224.
60. Afdhal, N., Reddy, K. R., Nelson, D. R., Lawitz,
E., Gordon, S. C., Schiff, E., . . . Herring, R.
Ledipasvir and sofosbuvir for previously treated
HCV genotype 1 infection. New England
Journal of Medicine, 2014;370(16): 1483-1493.
61. Feld, J. J., Kowdley, K. V., Coakley, E., Sigal, S.,
Nelson, D. R., Crawford, D., . . . Pilot-Matias, T.
Treatment of HCV with ABT-450/r–ombitasvir
and dasabuvir with ribavirin. New England
Journal of Medicine, 2014;370(17): 1594-1603.
62. Backmund, M., Meyer, K., Von Zielonka, M., &
Eichenlaub, D. Treatment of hepatitis C infection
in injection drug users. Hepatology, 2001;34(1):
188-193.
63. Karoney, M. J., & Siika, A. M. Hepatitis C virus
(HCV) infection in Africa: a review. Pan African
Medical Journal,2013; 14(1).
64. Alavian, S. M. (2009). Hepatitis C infection in
Iran; A review article.
65. Alavian, S. M., AHMADZADASL, M.,
BAGHERI, L. K., SHAH, B. M. A., Bahrami, A.
A., & Kabir, A. (2009). Hepatitis C infection in
the general population of Iran: a systematic
review.
66. Benova, L., Mohamoud, Y. A., Calvert, C., &
Abu-Raddad, L. J. Vertical transmission of
hepatitis C virus: systematic review and meta-
analysis. Clinical infectious diseases,
2014;59(6): 765-773.
Page 1896
 IAJPS 2018, 05 (03), 1885-1897
67. Shalmani, H. M., Ranjbar, M., & Alizadeh, A. H.
M. Recommendations for prevention and control
of hepatitis C virus (HCV) infection and HCV-
related chronic disease. J Liver,2013; 3(147):
2167-0889.1000147.
68. Chevaliez, S., & Pawlotsky, J.-M. Hepatitis C
virus serologic and virologic tests and clinical
diagnosis of HCV-related liver disease.
International journal of medical sciences,2006;
3(2): 35.
www.iajps.com
Sheikh Ahmed et al ISSN 2349-7750
69. Shepard, C. W., Finelli, L., & Alter, M. J. Global
epidemiology of hepatitis C virus infection. The
Lancet infectious diseases,2005; 5(9):558-567.
70. Edlin, B. R., Kresina, T. F., Raymond, D. B.,
Carden, M. R., Gourevitch, M. N., Rich, J.
D.,Cargill, V. A. Overcoming barriers to
prevention, care, and treatment of hepatitis C in
illicit drug users. Clinical infectious diseases,
2005;40(Supplement_5): S276-S285.
Page 1897